tradingkey.logo

Cryoport Inc

CYRX
查看詳細走勢圖
8.720USD
+0.120+1.40%
收盤 02/06, 16:00美東報價延遲15分鐘
436.60M總市值
6.92本益比TTM

Cryoport Inc

8.720
+0.120+1.40%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.40%

5天

-8.31%

1月

-18.20%

6月

+6.34%

今年開始到現在

-9.17%

1年

+28.05%

查看詳細走勢圖

TradingKey Cryoport Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Cryoport Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力較大。當前估值合理,在貨運與物流服務行業排名31/75位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為13.22。中期看,股價處於平穩狀態。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Cryoport Inc評分

相關信息

行業排名
31 / 75
全市場排名
161 / 4521
所屬行業
貨運與物流服務

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Cryoport Inc亮點

亮點風險
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入228.38M美元
估值低估
公司最新PB估值0.92,處於3年歷史低位
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉58.81K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.90

分析師目標

基於 9 分析師
買入
評級
13.222
目標均價
+42.17%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Cryoport Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Cryoport Inc簡介

Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
公司代碼CYRX
公司Cryoport Inc
CEOShelton (Jerrell Wilson)
網址https://www.cryoport.com/
KeyAI